Pacira BioSciences (NASDAQ:PCRX) announced plans to lay off 71 employees, nearly 8% of its total workforce, on Thursday, ...

After years of investment to upgrade its manufacturing capabilities, Pacira BioSciences figures it’s time to retire a facility that has been running for more than a decade. | After years spent ...

Pacira BioSciences plans to lay off 8% of its work force as it decommissioned one of its large-scale manufacturing suites.

Pacira BioSciences (NASDAQ:PCRX) stock falls as the company announces plans to cut its workforce by nearly 8% due to manufacturing upgrades for Exparel. Read more here.

Pacira BioSciences, Inc. (NASDAQ: PCRX) disclosed Wednesday that it has implemented a workforce reduction at its Science Center Campus in San Diego, California. The decision follows the company ...

Pacira is also pursuing an appellate review at the Federal Circuit for the New Jersey Court’s finding that the company’s U.S. Patent No. 11,033,495 (the ‘495 patent) is not valid.

Pacira has three commercial-stage non-opioid treatments: EXPAREL ® (bupivacaine liposome injectable suspension), a long-acting, local analgesia currently approved for postsurgical pain management ...

Pacira BioSciences, Inc. (NASDAQ:PCRX) Q2 2023 Earnings Conference Call August 2, 2023 8:30 AM ETCompany ParticipantsSusan Mesco - Head of IRDavid Stack - ...

SAN DIEGO, Feb. 5, 2025 /PRNewswire/ -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Pacira BioSciences ...

PARSIPPANY, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of ...

Pacira BioSciences, Inc. (NASDAQ: PCRX) disclosed Wednesday that it has implemented a workforce reduction at its Science Center Campus in San Diego, California. The decision follows the company’s move ...

This patent is the first patent from a new family of patents related to EXPAREL produced by the company’s enhanced large-scale manufacturing process in San Diego, which received approval from ...